Polyrizon Ltd. (PLRZ )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol PLRZ
- Company Polyrizon Ltd.
- Price $0.91
- Changes Percentage 0.04
- Change 0.0004
- Day Low $0.87
- Day High $0.93
- Year High $1200
- Year Low $0.55
- Market Cap $6,660,415
- Price Avg 50 EMA (D) $87.24
- Price Avg 200 EMA (D) $226.94
- Exchange NASDAQ
- Volume 31,471,072
- Average Volume 1,696,592
- Open $0.9
- Previous Close $0.91
- EPS -151.7
- PE -0.01
- Earnings Announcement 1970-01-01 00:00:00
- Shares Outstanding $5,328,332
Company brief: POLYRIZON LTD. (PLRZ )
- Healthcare
- Biotechnology
- Mr. Tomer Izraeli
- https://www.polyrizon-biotech.com
- IL
- N/A
- 10-29-2024
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.